Panhematin
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.panhematin.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Panhematin
Recordati Rare Diseases Inc. offers PANHEMATIN® (hemin for injection), the first FDA-approved medication for the relief of repeated attacks of acute intermittent porphyria (AIP), particularly in women when carbohydrate therapy is insufficient. The company focuses on providing effective treatment options and personalized support to patients managing AIP. Their product aims to prevent critical nerve damage during AIP attacks and is administered via intravenous infusion. Recordati Rare Diseases targets healthcare professionals and individuals affected by AIP, offering valuable resources and information about the condition and treatment options.Explore more
Popular SearchesPanhematinPANHEMATIN.comSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Panhematin your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Panhematin has new funding data
Panhematin, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Panhematin is spiking on competitors!
Check if Panhematin has recently received funding, and reach out quickly before it becomes old news!
Click to see if Panhematin had a recent Job posting/layoffs
Product Launch: Get notified when Panhematin launches new products
Congratulate Masked Content for being promoted to Masked Content at Panhematin
Earning: See what the market has to say on Panhematin recently announced quarterly report
Recommended Actions
Find VP level buyers at Panhematin
Find 3 more new buyers
Compare Similar Companies to Panhematin
Compare insights from companies similar to Panhematin, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Panhematin
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Panhematin is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Panhematin is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Panhematin.
Panhematin Tech Stack
A closer look at the technologies used by Panhematin
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Panhematin
Sign Up For FreeTo access detailed company insights
Recordati Rare Diseases Inc. offers PANHEMATIN® (hemin for injection), the first FDA-approved medication for the relief of repeated attacks of acute intermittent porphyria (AIP), particularly in women when carbohydrate therapy is insufficient. The company focuses on providing effective treatment options and personalized support to patients managing... Read More
